CHEMED CORPORATION Revenue from Contract with Customer, Excluding Assessed Tax
CHEMED CORPORATION (CHE) reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.53 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-02-28
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $411.01M, a 17.43% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $391.41M, a 17.28% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $374.56M, a 16.74% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2024-03-31 was $354.01M, a 14.02% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.53B, a 16.42% increase from fiscal 2023.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.32B, a 9.45% increase from fiscal 2022.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.20B, a 4.73% decline from fiscal 2021.
- CHEMED CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2021 was $1.26B, a 5.50% decline from fiscal 2020.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $411.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $802.41M derived: sum of 2 quarters · filed 2025-02-28 | $1.18B derived: sum of 3 quarters · filed 2025-02-28 | $1.53B 10-K · filed 2025-02-28 |
| 2024-09-30 | $391.41M 10-Q · filed 2024-11-01 | $765.96M derived: sum of 2 quarters · filed 2024-11-01 | $1.12B 10-Q · filed 2024-11-01 | $1.47B derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | $374.56M 10-Q · filed 2024-07-26 | $728.56M 10-Q · filed 2024-07-26 | $1.08B derived: sum of 3 quarters · filed 2025-02-28 | $1.41B derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $354.01M 10-Q · filed 2024-04-29 | $704.01M derived: sum of 2 quarters · filed 2025-02-28 | $1.04B derived: sum of 3 quarters · filed 2025-02-28 | $1.36B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $683.73M derived: sum of 2 quarters · filed 2025-02-28 | $1.00B derived: sum of 3 quarters · filed 2025-02-28 | $1.32B 10-K · filed 2025-02-28 |
| 2023-09-30 | $333.73M 10-Q · filed 2024-11-01 | $654.59M derived: sum of 2 quarters · filed 2024-11-01 | $965.07M 10-Q · filed 2024-11-01 | $1.27B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $320.86M 10-Q · filed 2024-07-26 | $631.34M 10-Q · filed 2024-07-26 | $939.40M derived: sum of 3 quarters · filed 2025-02-28 | $1.24B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $310.48M 10-Q · filed 2024-04-29 | $618.54M derived: sum of 2 quarters · filed 2025-02-28 | $915.07M derived: sum of 3 quarters · filed 2025-02-28 | $1.21B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $308.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $604.59M derived: sum of 2 quarters · filed 2025-02-28 | $902.38M derived: sum of 3 quarters · filed 2025-02-28 | $1.20B 10-K · filed 2025-02-28 |
| 2022-09-30 | $296.54M 10-Q · filed 2023-10-27 | $594.32M derived: sum of 2 quarters · filed 2023-10-27 | $893.51M 10-Q · filed 2023-10-27 | $1.21B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $297.78M 10-Q · filed 2023-07-28 | $596.97M 10-Q · filed 2023-07-28 | $913.08M derived: sum of 3 quarters · filed 2024-02-29 | $1.23B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $299.19M 10-Q · filed 2023-04-28 | $615.30M derived: sum of 2 quarters · filed 2024-02-29 | $932.71M derived: sum of 3 quarters · filed 2024-02-29 | $1.24B derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $316.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $633.52M derived: sum of 2 quarters · filed 2024-02-29 | $945.46M derived: sum of 3 quarters · filed 2024-02-29 | $1.26B 10-K · filed 2024-02-29 |
| 2021-09-30 | $317.41M 10-Q · filed 2022-11-02 | $629.35M derived: sum of 2 quarters · filed 2022-11-02 | $945.13M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $311.94M 10-Q · filed 2022-07-29 | $627.72M 10-Q · filed 2022-07-29 | ||
| 2021-03-31 | $315.79M 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | $1.33B 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $1.28B 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $1.20B 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |